Manufacturer record
Strain Healthcare 115: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Strain Healthcare 115 were declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T-2565, Diclofenac Sodium Tablet 50 mg (exp Jun 2028). DTL, Jaipur (state lab) found it not of standard quality: The sample does not conforms to the claim with respect to Assay of Diclofenac Sodium. Listed in the September 2026 alert.
Records by type
3 records linked to Strain Healthcare 115 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Tablet 50 mg | Batch T-2565Mfg ? · Exp Jun 2028 | The sample does not conforms to the claim with respect to Assay of Diclofenac Sodium.Assay | DTL, JaipurState lab | Sep 2026 |
| Diclofenac Sodium 50 mg + Caffeine 50 mg Tablets) | Batch T25-07Mfg Jun 2025 · Exp May 2028 | The sample does not conforms to the claim with respect to Caffeine (Anhydrous) Nil.Other | DTL, JaipurState lab | Sep 2026 |
| Diclofenac Sodium 50 mg + Caffeine 50 mg Tablets | Batch T25-08Mfg Jul 2025 · Exp Jun 2028 | The sample does not conforms to the claim with respect to Caffeine (Anhydrous) Nil.Other | DTL, JaipurState lab | Sep 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.